PGHL.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: September 03, 2025

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Procter & Gamble Health Ltd (PGHL.NS)

Based on 7 analysts giving stock ratings to Procter & Gamble Health Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
57
Hold
14
Sell
0
Strong Sell
0
Procter & Gamble Health Ltd

Procter & Gamble Health Ltd. Stock Analysis PGHL.NS

India Health Care Small Cap Report:
Procter & Gamble Health Ltd. engages in the manufacture and marketing of pharmaceuticals products. The company is headquartered in Mumbai, Maharashtra. The firm is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The firm is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Read More

Procter & Gamble Health Ltd (PGHL.NS) Chart

Procter & Gamble Health Ltd (PGHL.NS) vs Nifty 50 Comparative Returns

Analysis of Procter & Gamble Health Ltd (PGHL.NS) stock performance compared to the broader market (Nifty 50) across multiple timeframes.

YTD Performance
  • Procter & Gambl... (PGH...) 20.05%
  • Nifty 50 3.1%
Procter & Gambl... Outperformed Nifty 50 by 16.95%
1Y Performance
  • Procter & Gambl... (PGH...) 19.9%
  • Nifty 50 -2.68%
Procter & Gambl... Outperformed Nifty 50 by 22.58%
3Y Performance
  • Procter & Gambl... (PGH...) 59.89%
  • Nifty 50 37.83%
Procter & Gambl... Outperformed Nifty 50 by 22.06%
5Y Performance
  • Procter & Gambl... (PGH...) 27.95%
  • Nifty 50 110.16%
Procter & Gambl... Underperformed Nifty 50 by 82.21%

Key Statistics of Procter & Gamble Health Ltd (PGHL.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹6,263.00₹6,380.50

Today's Open

₹6,379.50

Volume

7666.00

P/E Ratio (TTM)

48.90

52 Week Range

₹4,863.00₹6,175.50

Market Cap

104.94B

Avg. Volume

14.17K

Dividend Yield

5.74%

Financial Metrics & Statements of Procter & Gamble Health Ltd (PGHL.NS)

FAQ's for Procter & Gamble Health Ltd (PGHL.NS)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.